Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Grant Of Licence/Regulatory Approval For Import Of Folicolor- Oxidative Hair Colour.
Filed with BSE · · 2 pages · English
Summary by 6ix AI
Amwill Health Care Ltd has announced the grant of a new licence for the import of FoliColor- Oxidative hair colour products into India, as per SEBI regulations. The approval was issued by the Central Drugs Standard Control Organization and is valid for a period of five years. This licence allows the company to expand its product portfolio and is expected to enhance revenue opportunities. The company has also confirmed that this is a new grant and not a renewal or amendment.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Amwill Health Care
- Amwill Health Care Ltd Press Release Sep 28 2026
- Amwill Health Care Ltd Press Release Sep 25 2026
- Amwill Health Care Ltd Press Release Aug 14 2026
- Amwill Health Care Ltd Press Release Aug 08 2026
- Amwill Health Care Ltd Press Release Jul 23 2026
Later from Amwill Health Care
- Board Meeting Intimation for Approval And Take On Record Unaudited Financial Results Of The Company For The Half Year Ended September 30, 2026 (H1) Of Financial Year 2026-27 And Consider Declaration Of An Interim Dividend To The Equity Shareholders.
- Board Meeting Outcome for Board Meeting Outcome Of The Meeting Of The Board Of Directors Held On October 23Rd, 2026.
- Approval Of Unaudited Financial Results Of The Company For The Half Year Ended September 30, 2026, For The Financial Year 2026-27.
- Disclosure Under Regulation 42 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
- Corporate Action-Board approves Dividend
Follow Amwill Health Care into a list and get an email when it puts out news.
Follow Amwill Health Care